SEC Form 4 · accession 0000907654-26-000102
Oruka Therapeutics, Inc. · ORKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arjun Agarwal
Officer — Senior Vice President, Finance
Period of report
Sep 21, 2026
Accepted (ET)
Sep 21, 2026 · 5:38 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000907654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 21, 2026 | S | 533 | $95.75 | D | 14,219 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.